Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

OSI PHARMACEUTICALS INC (OSIP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Sep-30-04Sep-30-03
   10-K10-K10-K10-K10-K10-K10-K10-K/A
Revenues  428.1379.4341.0241.0138.412.342.832.4
            Revenue growth  12.9%11.2%41.5%74.1%1021.1% 32.2% 
Cost of goods sold  8.89.39.48.75.0-1.29.00.2
Gross profit  419.4370.1331.6232.4133.413.633.832.2
            Gross margin  97.9%97.5%97.2%96.4%96.4%110.1%79.0%99.5%
Selling, general and administrative  103.094.999.2107.589.220.398.970.5
Research and development  151.8135.3123.5117.5116.731.9110.4102.6
EBITDA   [+]173.7147.8117.739.8-59.0 -159.2 
            EBITDA margin  40.6%39.0%34.5%16.5%-42.7% -371.9% 
Depreciation  9.18.08.832.413.4 16.3 
EBITA  164.5139.8108.97.4-72.5-46.3-175.5-141.0
            EBITA margin  38.4%36.8%31.9%3.1%-52.4%-374.9%-410.0%-435.5%
Amortization of intangibles  0.92.51.81.815.33.818.69.3
EBIT   [+]163.6137.3107.15.6-87.8-50.1-194.1-150.3
            EBIT margin  38.2%36.2%31.4%2.3%-63.4%-405.7%-453.5%-464.2%
Non-recurring items   [+]11.04.09.7 3.5 57.431.5
Interest income, net   [+]-27.1-22.421.4574.8-5.0 -13.4-6.7
Other income (expense), net  7.79.7-19.3-573.711.2 4.57.1
Pre-tax income  133.3120.799.56.7-85.10.0-260.4-181.4
Income taxes  57.3-316.02.70.00.00.00.00.0
            Tax rate  43.0% 2.7%0.0%0.0%0.0%0.0%0.0%
Net income  75.9441.660.56.7-157.10.0-260.4-181.4
            Net margin  17.7%116.4%17.7%2.8%-113.5%0.0%-608.3%-560.3%
   
Basic EPS   [+]$1.31$7.62$1.68$117.67($1.63)$0.00($6.50)($4.87)
Diluted EPS   [+]$1.26$6.53$1.66$116.23($1.63)$0.00($6.50)($4.87)
   
Shares outstanding (basic)   [+]57.957.357.70.152.147.440.137.2
Shares outstanding (diluted)   [+]60.566.958.30.152.147.440.137.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy